ADMA Biologics Inc.

Company Overview

ADMA Biologics is a biopharmaceutical company that manufactures products used in immune technology. The company develops therapies that treat infection in immunodeficient patients. Through its subsidiary, ADMA BioCenters, the company operates FDA-licensed source plasma collection facilities in the U.S.

Currently, ADMA has six plasma collection centers and four centers in development. The company aims to have 10 FDA-licensed operational plasma collection centers by the end of 2023. ADMA’s key customers include BioCARE Inc., Reliance Life Sciences Pvt Limited, AmerisourceBergen Corporation and Priority Healthcare Distribution Inc. These companies generated 81% of ADMA’s revenues in 2021.

Financial Highlights (FY 2024)

Company's Business Segments

• ADMA BioManufacturing : This segment reflects the company’s immune globulin manufacturing and development operations in Florida.
• Plasma Collection Centers : This segment includes ten plasma collection facilities, all of which were operational, collected plasma, and held an approved license with the FDA.